🚀 RECENT AI SUCCESS

Our AI successfully predicted the gap for $PUB.PA and executed a BUY strategy, securing a +9.52% net profit.

UPGRADE TO SEE LIVE SIGNALS

$ESPR

Esperion Therapeutics Inc

United StatesUNITED STATES
FREE PREVIEW
📅 Next Earnings: Aug 04, 2026 🌙 Close🌐 Website🏛️ NASDAQ📁 Health Technology🏭 Pharmaceuticals Major
AVG HISTORICAL GAP2.07%
MAX GAP RECORD12.26%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

VOLATILITY & BIAS PROFILE

AVG VOLATILITY6.4%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

Esperion Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of oral therapies for elevated low-density lipoprotein cholesterol. The firm offers NEXLETOL (bempedoic acid) tablets, and NEXLIZET (bempedoic acid and ezetimibe) tablets. The company was founded by Roger S. Newton, Hans Ageland, Jan O. Johansson, Anders Paul Wiklund, Michael E. Pape, David I. Scheer and Charles… Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL

AI INSIGHTS & REPORTS FOR ESPR

AI REPORT Jun 29

Sector Analysis: Market Sentiment Shifts Amid Global Economic Volatility

AnalysisMarkets worldwide are experiencing a wave of volatility as sectors ranging from technology to precious metals grapple with…
VIEW REPORT_
AI REPORT Jun 22

Navigating Overnight Gaps: A Quantitative Guide to Trading Strategy

Analysis Markets are no stranger to sudden shifts, and one of the most challenging scenarios for traders is…
VIEW REPORT_